Benitec Biopharma Inc. (BNTC) › Shareholders' EquityBenitec Biopharma Inc. (BNTC) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: $13.84M2019: $16.59M2020: $10.24M2021: $20.01M2022: $2.88M2023: $202.0K2024: $47.25M2025: $97.30M$97.30M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$97.30M+105.9%2024$47.25M+23290.1%2023$202.0K-93.0%2022$2.88M-85.6%2021$20.01M+95.4%2020$10.24M-38.3%2019$16.59M+19.9%2018$13.84M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share